Companies › JBIO

JADE BIOSCIENCES INC (JBIO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001798749 · EDGAR filings · Updated 2026-07-17

JADE BIOSCIENCES INC (JBIO) has reported institutional ownership of 101.0%, with 120 institutional managers holding positions valued at $700.3M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-17 — SCHEDULE 13G filed
• 2026-07-08 — SCHEDULE 13G/A filed
• 2026-07-01 — Current report (8-K) filed
• 2026-06-26 — Insider transaction reported (Form 4)
• 2026-06-26 — Initial insider ownership filed (Form 3)
• 2026-06-26 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, JADE BIOSCIENCES INC has 120 institutional holders and institutional ownership of 101.0%.

Insider activity

Insiders reported 7 transactions (1 buys, 0 sells) across 7 reporting insiders, with a net reported value of $44.4K.

Data flags from SEC filings

Related companies

IRADIMED CORP (IRMD) · SOLID BIOSCIENCES INC (SLDB) · VOR BIOPHARMA INC (VOR) · LB PHARMACEUTICALS INC (LBRX) · KURA ONCOLOGY INC COM (KURA) · CASTLE BIOSCIENCES INC (CSTL)